Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > And away from politics

<< Previous

Bullboard Posts

Next >>

Comment by Johnandrose22on Jun 02, 2021 7:57pm

153 Views

Post# 33316184

RE:RE:And away from politics

Although I am pleased and relieved that the company has addressed issues related to Phase II patients 1-12 I am still struggling to grasp what actually occurred to produce those initial results.

Did the patients not receive the therapeutic dose of TLD 1433 at 0.70 mg/cm....or was the accompanying solution into the bladder insufficient....or was the light to stimulate the PDC not enough...or was it a combination of all three and maybe more.

The more knowledgeable members of our discussion board might help me with this.

Thanks in advance.

John

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing